Dar Al Dawa Development and Investment Co. Ltd.

ASE-DADI
Amman Stock Exchange
Pharmaceutical Preparations
Global Rank
#28747
Country Rank
#32
Market Cap
57.26 M
Price
1.64
Change (%)
1.75%
Volume
3,735

Dar Al Dawa Development and Investment Co. Ltd.'s latest marketcap:

57.26 M

As of 07/05/2025, Dar Al Dawa Development and Investment Co. Ltd.'s market capitalization has reached $57.26 M. According to our data, Dar Al Dawa Development and Investment Co. Ltd. is the 28747th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 57.26 M
Revenue (ttm) 116.89 M
Net Income (ttm) 5.2 M
Shares Out 35 M
EPS (ttm) 0.15
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 07/31/2025
Market Cap Chart
Data Updated: 07/05/2025

Dar Al Dawa Development and Investment Co. Ltd.'s yearly market capitalization.

Dar Al Dawa Development and Investment Co. Ltd. has seen its market value drop from د.أ80.5 M to د.أ57.26 M since 2014, representing a total decrease of 28.87% and an annual compound decline rate (CAGR) of 3.19%.
Date Market Cap Change (%) Global Rank
07/05/2025 د.أ57.26 M -7.94% 28747
12/31/2024 د.أ44.1 M -4.55% 26462
12/31/2023 د.أ46.2 M 23.36% 26008
12/29/2022 د.أ37.45 M -6.96% 26496
12/30/2021 د.أ40.25 M 40% 26784
12/31/2020 د.أ28.75 M 8.49% 25888
12/31/2019 د.أ26.5 M 19.1% 23467
12/31/2018 د.أ22.25 M -52.41% 23411
12/31/2017 د.أ46.75 M -13.02% 20167
12/29/2016 د.أ53.75 M -7.33% 17269

Company Profile

About Dar Al Dawa Development and Investment Co. Ltd.

Dar Al Dawa Development and Investment Co. Ltd. is a leading integrated pharmaceutical company specializing in the development, manufacturing, marketing, and distribution of pharmaceutical and consumer healthcare products. With a strong presence across multiple regions, the company serves markets in:

  • Levant, Gulf, and Yemen
  • The Middle East
  • Africa
  • Europe
  • Asia

Business Segments

The company operates through two key segments:

  • Medicine: Offers a wide range of pharmaceutical products across various therapeutic areas.
  • Infants’ Cereals and Milk Formula: Provides specialized nutrition products for infants.

Therapeutic Areas

Dar Al Dawa’s pharmaceutical portfolio covers multiple therapeutic categories, including:

  • Anti-infective
  • Cardiovascular and diabetes
  • Urology
  • Respiratory
  • Gastrointestinal
  • Analgesic and musculoskeletal
  • Central nervous system
  • Gynecology
  • Dermatology
  • Ophthalmology
  • Oncology

Company Overview

Founded in 1975, Dar Al Dawa Development and Investment Co. Ltd. is headquartered in Amman, Jordan. The company is committed to serving patients and medical communities with high-quality healthcare solutions.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.